Morgan Barense

Canada Research Chair in Cognitive Neuroscience

Tier 2 - 2014-10-01
Renewed: 2019-10-01
University of Toronto
Natural Sciences and Engineering Research Council


Research involves

Using imaging techniques to understand how memory loss occurs, and developing a theory of amnesia that accounts for the interrelationships between memory and perception.

Research relevance

This research will reshape our understanding of brain disorders and memory loss, and could change the way these disorders are treated.

Detecting early Alzheimer disease

Early detection of Alzheimer’s disease (AD) is essential because treatments will only be effective before irreversible brain damage has occurred. Dr. Morgan Barense, Canada Research Chair in  Cognitive Neuroscience, will apply recent neuroscience discoveries to develop sensitive markers for preclinical AD.

Unlike other methods that require a lumbar puncture or exposure to radiation, her measures are non-invasive. They can therefore be administered repeatedly to asymptomatic individuals, enabling screening of more people. Barense will also provide an effective, inexpensive, non-invasive Digital Memory Augmentation device that externally mimics AD-compromised brain function. Improved early detection measures will enable the administration of this intervention at the most effective time.